Lv3
202 积分 2023-07-14 加入
Cancer nanomedicine: progress, challenges and opportunities
8天前
已完结
Controlling the biodistribution and clearance of nanomedicines
8天前
已完结
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer
10天前
已完结
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
1个月前
已完结
The mechanisms of nanoparticle delivery to solid tumours
2个月前
已完结
Additivity predicts the efficacy of most approved combination therapies for advanced cancer
2个月前
已完结
Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors
2个月前
已完结
Linking macrophage metabolism to function in the tumor microenvironment
4个月前
已完结
Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis
5个月前
已完结
Therapeutic Targeting of the Tumor Microenvironment
5个月前
已完结
皖公网安备34019202002308
